Large gap with delayed quotes
|
Last quote
05/30/2026
-
02:00:00
|
Bid
05/29/2026 -
21:59:56
|
Bid Volume |
Ask
05/29/2026 -
21:59:56
|
Ask Volume |
|---|---|---|---|---|
|
447.54
-0.43
(
-0.10% )
|
447.56
|
240 |
447.72
|
3,360 |
Analysis date: 26.05.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 03.04.2026.
Interest
Very weak
Very weak
One star since 14.04.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 03.04.2026 at a price of 438.71.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 17.03.2026.
4wk Rel Perf
-3.63%
-3.63%
The four-week dividend-adjusted underperformance versus SP500 is 3.63%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 20.02.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.31%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.01%.
Mkt Cap in $bn
110.28
110.28
With a market capitalization >$8bn, VERTEX PHARMA INC is considered a large-cap stock.
G/PE Ratio
0.88
0.88
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
17.37
17.37
The estimated PE is for the year 2028.
LT Growth
15.27%
15.27%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
26
26
Over the last seven weeks, an average of 26 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
48
48
For 1% of index variation, the stock varies on average by 0.48%.
Correlation
0.20
0.20
Stock movements are totally independent of index variations.
Value at Risk
104.62
104.62
The value at risk is estimated at USD 104.62. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002